scholarly journals Transkingdom network reveals bacterial players associated with cervical cancer gene expression program

PeerJ ◽  
2018 ◽  
Vol 6 ◽  
pp. e5590 ◽  
Author(s):  
Khiem Chi Lam ◽  
Dariia Vyshenska ◽  
Jialu Hu ◽  
Richard Rosario Rodrigues ◽  
Anja Nilsen ◽  
...  

Cervical cancer is the fourth most common cancer in women worldwide with human papillomavirus (HPV) being the main cause the disease. Chromosomal amplifications have been identified as a source of upregulation for cervical cancer driver genes but cannot fully explain increased expression of immune genes in invasive carcinoma. Insight into additional factors that may tip the balance from immune tolerance of HPV to the elimination of the virus may lead to better diagnosis markers. We investigated whether microbiota affect molecular pathways in cervical carcinogenesis by performing microbiome analysis via sequencing 16S rRNA in tumor biopsies from 121 patients. While we detected a large number of intra-tumor taxa (289 operational taxonomic units (OTUs)), we focused on the 38 most abundantly represented microbes. To search for microbes and host genes potentially involved in the interaction, we reconstructed a transkingdom network by integrating a previously discovered cervical cancer gene expression network with our bacterial co-abundance network and employed bipartite betweenness centrality. The top ranked microbes were represented by the familiesBacillaceae,Halobacteriaceae, andPrevotellaceae. While we could not define the first two families to the species level,Prevotellaceaewas assigned toPrevotella bivia. By co-culturing a cervical cancer cell line withP. bivia, we confirmed that three out of the ten top predicted genes in the transkingdom network (lysosomal associated membrane protein 3 (LAMP3), STAT1, TAP1), all regulators of immunological pathways, were upregulated by this microorganism. Therefore, we propose that intra-tumor microbiota may contribute to cervical carcinogenesis through the induction of immune response drivers, including the well-known cancer gene LAMP3.

2018 ◽  
Author(s):  
Khiem Chi Lam ◽  
Dariia Vyshenska ◽  
Jialu Hu ◽  
Richard Rosario Rodrigues ◽  
Anja Nilsen ◽  
...  

Cervical cancer is the fourth most common cancer in women worldwide with human papillomavirus (HPV) being the main cause of disease. Chromosomal amplifications have been identified as a source of upregulation of cervical cancer driver genes but cannot fully explain increased expression of immune genes in invasive carcinoma. Insight into additional factors that may tip the balance from making the immune system tolerate HPV to eliminate the virus may lead to markers for better diagnosis. We investigated whether microbiota affect molecular pathways in cervical carcinogenesis by performing microbiome analysis via sequencing 16S rRNA in tumor biopsies from 121 patients. While we detected a large number of intra-tumor taxa (289 OTUs), we focused on the thirty-eight most abundantly represented microbes. To search for microbes and host genes potentially involved in the interaction, we reconstructed a transkingdom network by integrating previously discovered cervical cancer gene expression network with our bacterial co-abundance network and employed bipartite betweenness centrality (BiBC). The top ranked microbes were represented by the families Bacillaceae, Halobacteriaceae, and Prevotellaceae. While we could not define the first two families to the species level, Prevotellaceae was assigned to Prevotella bivia. By co-culturing a cervical cancer cell line with P. bivia, we confirmed that three out of ten top predicted genes in the transkingdom network (LAMP3, STAT1, TAP1), all regulators of immunological pathways, were upregulated by this microorganism. Therefore, we propose that intra-tumor microbiota might contribute to cervical carcinogenesis through the induction of immune response drivers, including the well-known cancer gene LAMP3.


2018 ◽  
Author(s):  
Khiem Chi Lam ◽  
Dariia Vyshenska ◽  
Jialu Hu ◽  
Richard Rosario Rodrigues ◽  
Anja Nilsen ◽  
...  

Cervical cancer is the fourth most common cancer in women worldwide with human papillomavirus (HPV) being the main cause of disease. Chromosomal amplifications have been identified as a source of upregulation of cervical cancer driver genes but cannot fully explain increased expression of immune genes in invasive carcinoma. Insight into additional factors that may tip the balance from making the immune system tolerate HPV to eliminate the virus may lead to markers for better diagnosis. We investigated whether microbiota affect molecular pathways in cervical carcinogenesis by performing microbiome analysis via sequencing 16S rRNA in tumor biopsies from 121 patients. While we detected a large number of intra-tumor taxa (289 OTUs), we focused on the thirty-eight most abundantly represented microbes. To search for microbes and host genes potentially involved in the interaction, we reconstructed a transkingdom network by integrating previously discovered cervical cancer gene expression network with our bacterial co-abundance network and employed bipartite betweenness centrality (BiBC). The top ranked microbes were represented by the families Bacillaceae, Halobacteriaceae, and Prevotellaceae. While we could not define the first two families to the species level, Prevotellaceae was assigned to Prevotella bivia. By co-culturing a cervical cancer cell line with P. bivia, we confirmed that three out of ten top predicted genes in the transkingdom network (LAMP3, STAT1, TAP1), all regulators of immunological pathways, were upregulated by this microorganism. Therefore, we propose that intra-tumor microbiota might contribute to cervical carcinogenesis through the induction of immune response drivers, including the well-known cancer gene LAMP3.


2021 ◽  
Vol 67 (3) ◽  
pp. 143-147
Author(s):  
Xue Jianfang ◽  
Zhu Ling ◽  
Jiao Yanan ◽  
Guan Yanliang

Chaihu-shugan-san, as a traditional Chinese herbal formula, is composed of seven different herbs. This medicine can treat cancer due to its antioxidant compounds. In this study, the effect of Chaihu-shugan-san was considered on cytotoxicity induction and PDGF gene expression in cervical cancer cell line HeLa at different concentrations and at different times, by the MTT method. Paclitaxel + cisplatin were used as a control in this study. The expression of the PDGF gene was quantitatively evaluated in treated cells by real-time PCR, and a generalized linear model was used to evaluate the effect of the medicine, and Duncan's multiple range tests were used to evaluate the data. The results of the MTT test showed that Chaihu-shugan-san had antitumor properties in different concentrations, but there was a significant difference between this medicine and paclitaxel +cisplatin. Also, examination of gene expression showed that this medicine reduced the expression of the PDGF gene in the HeLa cancer cell line (P ? 0.04). Therefore, Chaihu-shugan-san could be suggested as an effective factor in preventing the growth of cervical cancer cells and controlling angiogenic factors that play an important role in the metastasis of cancerous tumors.


Sign in / Sign up

Export Citation Format

Share Document